<DOC>
	<DOCNO>NCT02500082</DOCNO>
	<brief_summary>The purpose study determine whether triheptanoin ( UX007 ) effective treatment neurological symptom related citrate transporter deficiency ( SLC13A5 gene mutation ) .</brief_summary>
	<brief_title>Triheptanoin ( UX007 ) Treat Citrate Transporter Deficiency</brief_title>
	<detailed_description>This compassionate use research study develop study investigational drug , triheptanoin ( UX007 ) , treatment neurological symptom related citrate transporter deficiency , disease exist treatment . The hypothesis triheptanoin restore deficient energy metabolism patient , lead improved seizure control , mental clarity , physical strength . Based literature , SLC13A5 gene product citrate transporter . However , possibility compound transport well . The gene may express human neuron function level plasma membrane . The hypothesis transport citrate across plasma membrane extracellular space cytoplasm play role maintain pool size citrate cytoplasm mitochondrial matrix . Triheptanoin therapy may increase metabolism odd-chain fatty acid neuronal mitochondrion thereby increase level succinyl-CoA , leading increase citrate concentration . The increased level citrate mitochondrial matrix may lead increase efflux citrate matrix cytoplasm , thus increase cytoplasmic pool citrate allow malfunction citrate transporter bypass . If successful , triheptanoin treatment improve neuronal function lead improvement CNS function patient . While investigator follow course subject considerable interest may use collect data clinical research , study do humanitarian reason .</detailed_description>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Diagnosis citrate transporter deficiency due mutation SLC13A5 gene . Presentation severe global developmental delay seizure . Valproate AED partially inhibit TCA cycle via alphaketoglutarate dehydrogenase administer subject take UX007 .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>citrate transporter deficiency</keyword>
	<keyword>SLC13A5 gene</keyword>
	<keyword>citric acid cycle</keyword>
	<keyword>energy metabolism</keyword>
</DOC>